Antifungal and antidepressant drugs can effectively inhibit COVID-19 virus

New research published in the British Journal of Pharmacology indicates that two currently available medications–an antifungal drug and an antidepressant–can effectively inhibit the virus that causes COVID-19 in laboratory cells.

Investigators found that the antifungal itraconazole and the antidepressant fluoxetine each blocked the production of infectious SARS-CoV-2 virus in cell culture lab tests. When either drug was used in combination with the antiviral drug remdesiver, the combination showed synergistic effects and inhibited the production of SARS-CoV-2 by more than 90%.

Preventive vaccination and therapeutic medicines against COVID-19 are both required to effectively combat pandemics caused by emerging zoonotic viruses such as SARS-CoV-2.”

Ursula Rescher, PhD, Study Senior Author, University of Muenster, Germany

Fluoxetine Capsules USP 20mg Taj Pharma FDA approved, Fluoxetine Capsules USP 20mg Taj Pharma manufacturers, suppliers & exporters in India. Get contract manufacturing for Fluoxetine Capsules USP 20mg Taj Pharma, Find best price for Fluoxetine Capsules USP 20mg Taj Pharma generic drug and Fluoxetine Capsules USP 20mg Taj Pharma generic version available at best price from GMP approved manufacturer
Fluoxetine Capsules USP 20mg Taj Pharma Manufacturers, Suppliers & Exporters India – Taj Pharma {GMP Approved}

Source:

WileyJournal reference:

Schloer, S., et al. (2021) Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS‐CoV‐2 infection in vitro. British Journal of Pharmacology. doi.org/10.1111/bph.15418.

Reviewed by Emily Henderson, B.Sc.